Two aberrant splicings caused by mutations in the insulin receptor gene in cultured lymphocytes from a patient with Rabson-Mendenhall's syndrome.
Rabson-Mendenhall's syndrome is one of the most severe forms of insulin resistance syndrome. We analyzed an English patient described elsewhere and found novel mutations in both alleles of the insulin receptor gene. One is a substitution of G for A at the 3' splice acceptor site of intron 4, and the other is an eight-base pair deletion in exon 12. Both decrease mRNA expression in a cis-dominant manner, and are predicted to produce severely truncated proteins. Surprisingly, nearly normal insulin receptor levels were expressed in the patient's lymphocytes, although the level of expression assessed by immunoblot was approximately 10% of the control cells. Insulin binding affinity was markedly reduced, but insulin-dependent tyrosine kinase activity was present. Analyzing the insulin receptor mRNA of the patient's lymphocytes by reverse transcription PCR, we discovered aberrant splicing caused by activation of a cryptic splice site in exon 5, resulting in a four-amino acid deletion and one amino acid substitution, but restoring an open reading frame. Skipped exon 5, another aberrant splicing, was found in both the patient and the mother who had the heterozygotic mutation, whereas activation of the cryptic splice site occurred almost exclusively in the patient. Transfectional analysis in COS cells revealed that the mutant receptor produced by cryptic site activation has the same characteristics as those expressed in patient's lymphocytes. We speculate that this mutant receptor may be involved in the relatively long survival of the patient by rescuing otherwise more severe phenotypes resulting from the complete lack of functional insulin receptors.
Takahashi
Y
Y
Third Department of Internal Medicine, Faculty of Medicine, University of Tokyo, Tokyo 113-0033, Japan.
Kadowaki
H
H
Ando
A
A
Quin
J D
JD
MacCuish
A C
AC
Yazaki
Y
Y
Akanuma
Y
Y
Kadowaki
T
T
D000483:Alleles; D017398:Alternative Splicing; D000818:Animals; D019556:COS Cells; D002461:Cell Line, Transformed; D015870:Gene Expression; D006801:Humans; D007333:Insulin Resistance; D007438:Introns; D008214:Lymphocytes / Q000166:cytology / Q000378:metabolism*; D009154:Mutation; D012333:RNA, Messenger; D011972:Receptor, Insulin / Q000096:biosynthesis / Q000235:genetics*; D013577:Syndrome
D012333:RNA, Messenger; D011972:Receptor, Insulin